KEY FINDINGS By region, North America holds the highest market share in the global biosurgery market. It includes the U.S., Mexico and Canada. Over the forecast period of 2018-2026, the market is likely to progress with a 7.20% CAGR.
MARKET INSIGHTS The North American market holds a great demand for biological products such as hemostatic agents, anti-adhesive agents, surgical sealing agents, soft tissue management products and bone-graft substitutes. The U.S. is one of the top countries engaged in research and development in North America. The market is also progressing considerably in terms of biosurgery advancements and hence is expected to show the highest growth in the North American region by the end of 2026. However, stringent rules and regulations are expected to restrain the market during the forecast period
COMPETITIVE INSIGHTS Companies like Johnson & Johnson, Medtronic Plc, Stryker Corporation, Olympus Corporation, Baxter International Inc, Wright Medical Group N.V, RTI Surgical, Zimmer Biomet Holdings Inc, and Ethicon Inc are reigning this market
Our reports have been used by over 10K customers, including: